Center-Authored Papers

Filters: Author is Scott, Bart  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
W
Wang ES, Lyons RM, Larson RA, Gandhi S, Liu D, Matei C, Scott B, Hu K, Yang AS.  2012.  A randomized, double-blind, placebo-controlled phase 2 study evaluating the efficacy and safety of romiplostim treatment of patients with low or intermediate-1 risk myelodysplastic syndrome receiving lenalidomide.. Journal of hematology & oncology. 5:71. Abstract
S
Stein BL, Gotlib J, Arcasoy M, Nguyen MH, Shah N, Moliterno A, Jamieson C, Pollyea DA, Scott B, Wadleigh M et al..  2015.  Historical views, conventional approaches, and evolving management strategies for myeloproliferative neoplasms.. Journal of the National Comprehensive Cancer Network : JNCCN. 13(4):424-34. Abstract
Steensma DP, Abedi M, Bejar R, Cogle CR, Foucar K, Garcia-Manero G, George TI, Grinblatt D, Komrokji R, Ma X et al..  2016.  Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study.. BMC cancer. 16:652. Abstract
Scott B.  2012.  Myelodysplastic syndromes: increasing disease awareness. Discussion.. The American journal of medicine. 125(7 Suppl):S33-4.
Scott B.  2012.  Myelodysplastic syndromes: increasing disease awareness. Introduction.. The American journal of medicine. 125(7 Suppl):S1.
M
Mesa R, Jamieson C, Bhatia R, Deininger MW, Gerds AT, Gojo I, Gotlib J, Gundabolu K, Hobbs G, Klisovic RB et al..  2016.  Myeloproliferative Neoplasms, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.. Journal of the National Comprehensive Cancer Network : JNCCN. 14(12):1572-1611. Abstract
Mawad R, Gooley TA, Sandhu V, Lionberger J, Scott B, Sandmaier BM, O'Donnell P, Becker PS, Petersdorf S, Dorcy KS et al..  2013.  Frequency of allogeneic hematopoietic cell transplantation among patients with high- or intermediate-risk acute myeloid leukemia in first complete remission.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 31(31):3883-8. Abstract
Mawad R, Becker PS, Hendrie P, Scott B, Wood BL, Dean C, Sandhu V, Deeg HJ, Walter R, Wang L et al..  2016.  Phase II study of tosedostat with cytarabine or decitabine in newly diagnosed older patients with acute myeloid leukaemia or high-risk MDS.. British journal of haematology. 172(2):238-245. Abstract
G
Gyurkocza B, Gutman J, Nemecek ER, Bar M, Milano F, Ramakrishnan A, Scott B, Fang M, Wood B, Pagel JM et al..  2014.  Treosulfan, Fludarabine, and 2-Gy Total Body Irradiation Followed by Allogeneic Hematopoietic Cell Transplantation in Patients with Myelodysplastic Syndrome and Acute Myeloid Leukemia.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 20(4):549-55. Abstract
Greenberg PL, Stone RM, Bejar R, Bennett JM, Bloomfield CD, Borate U, De Castro CM, Deeg HJ, DeZern AE, Fathi AT et al..  2015.  Myelodysplastic syndromes, version 2.2015.. Journal of the National Comprehensive Cancer Network : JNCCN. 13(3):261-72. Abstract